The XPrize Healthspan competition, a seven-year initiative focused on advancing longevity innovations, has announced its top 10 finalists. These teams are exploring a range of anti-aging strategies, with a particular focus on technologies aimed at improving cellular health and function.
One notable approach among the finalists involves the use of exosomes, tiny vesicles secreted by cells that play a role in intercellular communication. A team from the University of Tokyo is developing "super exosomes" engineered to target aging cells specifically. Professor Keisuke Goda of the University of Tokyo explained that these exosomes are designed with surface molecules that act like magnets, attracting them to cells exhibiting signs of aging. This targeted delivery aims to replenish aging cells with essential compounds like lipids and genetic material, helping them maintain younger characteristics.
Previous research has indicated that exosomes contain various molecules, including growth factors and genetic material. Studies involving the injection of exosomes from younger sources into older mice have shown a rejuvenating effect. However, a significant challenge has been the efficient delivery of these exosomes to their intended cellular targets.
Goda's background in chemistry and engineering has been instrumental in addressing this delivery problem. The engineered exosomes are intended to overcome the limitations of previous methods by ensuring the therapeutic compounds reach the cells where they are most needed. The XPrize Healthspan competition is designed to accelerate the development and validation of such pioneering health and longevity innovations.